60度制药公司股价因犬巴贝斯虫病治疗计划而飙升

英为财情
Jul 15, 2025

Investing.com -- 60度制药公司( 60 Degrees Pharmaceuticals Inc)(NASDAQ:SXTP)股价跳涨20%,此前该公司宣布计划向美国食品药品监督管理局(FDA)申请"小规模使用小型物种"(MUMS)认证,用于其治疗急性犬巴贝斯虫病的他非诺喹(tafenoquine)药物。 这家专注于开发传染病药物的制药公司将在提交MUMS认证申请前对现有数据进行...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10